Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38452832)

  • 1. Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia.
    Yang T; Gou H; Lin T; Yang Y; Jin X; Dong T; Zhang Y; Chen X
    Int J Pharm; 2024 Apr; 654():123971. PubMed ID: 38452832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fisetin Inhibits Cell Proliferation through the Induction of G
    Tsai YH; Lin JJ; Ma YS; Peng SF; Huang AC; Huang YP; Fan MJ; Lien JC; Chung JG
    Am J Chin Med; 2019; 47(4):841-863. PubMed ID: 31096772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling.
    Adan A; Baran Y
    Tumour Biol; 2016 May; 37(5):5781-95. PubMed ID: 26408178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaempferol and Fisetin-Related Signaling Pathways Induce Apoptosis in Head and Neck Cancer Cells.
    Kubina R; Krzykawski K; Dziedzic A; Kabała-Dzik A
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks.
    Adan A; Baran Y
    Tumour Biol; 2015 Nov; 36(11):8973-84. PubMed ID: 26081618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells.
    Li J; Cheng Y; Qu W; Sun Y; Wang Z; Wang H; Tian B
    Basic Clin Pharmacol Toxicol; 2011 Feb; 108(2):84-93. PubMed ID: 21054790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 4'-brominated derivative of fisetin induces cell cycle arrest and apoptosis and inhibits EGFR/ERK1/2/STAT3 pathways in non-small-cell lung cancer without any adverse effects in mice.
    Sabarwal A; van Rooyen JC; Caburet J; Avgenikos M; Dheeraj A; Ali M; Mishra D; de Meester JSB; Stander S; van Otterlo WAL; Kaschula CH; Singh RP
    FASEB J; 2022 Dec; 36(12):e22654. PubMed ID: 36421014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa.
    Afroze N; Pramodh S; Shafarin J; Bajbouj K; Hamad M; Sundaram MK; Haque S; Hussain A
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells.
    Sabarwal A; Agarwal R; Singh RP
    Mol Carcinog; 2017 Feb; 56(2):499-514. PubMed ID: 27254419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
    Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
    Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells.
    Sundarraj K; Raghunath A; Panneerselvam L; Perumal E
    Biofactors; 2020 Jan; 46(1):118-135. PubMed ID: 31634424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter.
    Kim JA; Lee S; Kim DE; Kim M; Kwon BM; Han DC
    Carcinogenesis; 2015 Jun; 36(6):696-706. PubMed ID: 25840992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways.
    Zhang XJ; Jia SS
    Biomed Pharmacother; 2016 Oct; 83():1164-1174. PubMed ID: 27551764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti‑cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies.
    Sun X; Ma X; Li Q; Yang Y; Xu X; Sun J; Yu M; Cao K; Yang L; Yang G; Zhang G; Wang X
    Int J Mol Med; 2018 Aug; 42(2):811-820. PubMed ID: 29749427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
    Lim DY; Park JH
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1.
    Chen YC; Shen SC; Lee WR; Lin HY; Ko CH; Shih CM; Yang LL
    Arch Toxicol; 2002 Jun; 76(5-6):351-9. PubMed ID: 12107653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review.
    Kubina R; Krzykawski K; Kabała-Dzik A; Wojtyczka RD; Chodurek E; Dziedzic A
    Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models.
    Sechi M; Lall RK; Afolabi SO; Singh A; Joshi DC; Chiu SY; Mukhtar H; Syed DN
    Sci Rep; 2018 Oct; 8(1):15726. PubMed ID: 30356079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fisetin-loaded grape-derived nanoparticles improve anticancer efficacy in MOLT-4 cells.
    Sarvarian P; Samadi P; Gholipour E; Khodadadi M; Pourakbari R; Akbarzadelale P; Shamsasenjan K
    Biochem Biophys Res Commun; 2023 May; 658():69-79. PubMed ID: 37027907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of intravesical fisetin against bladder cancer by induction of p53 and down-regulation of NF-kappa B pathways in a rat bladder carcinogenesis model.
    Li J; Qu W; Cheng Y; Sun Y; Jiang Y; Zou T; Wang Z; Xu Y; Zhao H
    Basic Clin Pharmacol Toxicol; 2014 Oct; 115(4):321-9. PubMed ID: 24646039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.